Targeted contrast-enhanced ultrasound imaging of angiogenesis in an orthotopic mouse tumor model of renal carcinoma

Ultrasound in Medicine and Biology

Volumn 40, Issue 6, 2014, Pages 1250-1259

  Wei, Shuping ^a   Fu, Ninghua ^a   Sun, Yu ^b   Yang, Zhijian ^b   Lei, Li ^a   Huang, Pengfei ^a   Yang, Bin ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b Origin Biosciences ^*  (China)

Author keywords

Angiogenesis; Contrast agent; Contrast pulse sequence; Microbubbles; Molecular imaging; Nude mouse; Orthotopic; Renal clear cell carcinoma; Targeted ultrasound; Vascular endothelial growth factor receptor 2

Indexed keywords

ANTIBODIES; CELL ENGINEERING; MAMMALS; MOLECULAR IMAGING; ULTRASONIC IMAGING;

ANGIOGENESIS; CLEAR CELL CARCINOMA; CONTRAST AGENT; CONTRAST PULSE; MICROBUBBLES; NUDE MICE; ORTHOTOPIC; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR;

TUMORS;

VASCULOTROPIN RECEPTOR 2; CONTRAST MEDIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B SCAN; CONTRAST ENHANCED ULTRASOUND; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; ECHOGRAPHY; HUMAN; HUMAN CELL; IN VIVO STUDY; KIDNEY CAPSULE; KIDNEY CARCINOMA; KIDNEY PARENCHYMA; MALE; MICROBUBBLE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENAL CELL CARCINOMA CELL LINE; TUMOR GROWTH; TUMOR VASCULARIZATION; ANIMAL; BAGG ALBINO MOUSE; COLOR ULTRASOUND FLOWMETRY; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC USE; DISEASE MODEL; IMMUNOHISTOCHEMISTRY; KIDNEY TUMOR; METABOLISM; MOLECULAR IMAGING; NEOVASCULARIZATION (PATHOLOGY); NUDE MOUSE; PROCEDURES;

ANIMALS; CARCINOMA, RENAL CELL; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MALE; MICE, INBRED BALB C; MICE, NUDE; MICROBUBBLES; MOLECULAR IMAGING; NEOVASCULARIZATION, PATHOLOGIC; ULTRASONOGRAPHY, DOPPLER, COLOR; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84899933812     PISSN: 03015629     EISSN: 1879291X     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2013.12.001     Document Type: Article

References (34)

1. AmericanCancerSociety Cancer Facts and Figures2008 2008, American Cancer Society, Atlanta, GA.
2. Anderson C.R., Hu X., Tlaxca J., Decleves A.E., Houghtaling R., Sharma K., Lawrence M., Ferrara K., Rychak J.J. Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent. Invest Radiol 2011, 46:215-224.
3. Anderson C.R., Rychak J.J., Backer M., Backer J., Ley K., Klibanov A.L. scVEGF microbubble ultrasound contrast agents: A novel probe for ultrasound molecular imaging of tumor angiogenesis. Invest Radiol 2010, 45:579-585.
4. Cai W., Rao J., Gambhir S.S., Chen X. How molecular imaging is speeding up antiangiogenic drug development. Mol Cancer Therap 2006, 5:2624-2633.
5. Carmeliet P. Angiogenesis in life, disease and medicine. Nature 2005, 438:932-936.
6. Ellegala D.B., Leong-Poi H., Carpenter J.E., Klibanov A.L., Kaul S., Shaffrey M.E., Sklenar J., Lindner J.R. Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to αvβ3. Circulation 2003, 108:336-341.
7. Escudier B., Eisen T., Stadler W.M., Szczylik C., Oudard S., Siebels M., Negrier S., Chevreau C., Solska E., Desai A.A. Sorafenib in advanced clear-cell renal-cell carcinoma. NEngl J Med 2007, 356:125-134.
8. Fidler I.J., Naito S., Pathak S. Orthotopic implantation is essential for the selection, growth and metastasis of human real cell cancer in nude mice. Cancer Metast Rev 1990, 9:149-165.
9. Folkman J. Angiogenesis. Annu Rev Med 2006, 57:1-18.
10. Hicklin D.J., Ellis L.M. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. JClin Oncol 2005, 23:1011-1027.
11. Hu X., Caskey C.F., Mahakian L.M., Kruse D.E., Beegle J.R., Decleves A.E., Rychak J.J., Sutcliffe P.L., Sharma KFerrara K.W. Invivo validation and 3D visualization of broadband ultrasound molecular imaging. Am J Nucl Med Mol Imaging 2013, 3:336-349.
12. Jinzaki M., Tanimoto A., Mukai M., Ikeda E., Kobayashi S., Yuasa Y., Narimatsu Y., Murai M. Double-phase helical CT of small renal parenchymal neoplasms: Correlation with pathologic findings and tumor angiogenesis. JComput Assist Tomogr 2000, 24:835-842.
13. Jun H.Y., Park S.H., Kim H.S., Yoon K.H. Long residence time of ultrasound microbubbles targeted to integrin in murine tumor model. Acad Radiol 2010, 17:54-60.
14. Klibanov A.L. Microbubble contrast agents: Targeted ultrasound imaging and ultrasound-assisted drug-delivery applications. Invest Radiol 2006, 41:354-362.
15. Korpanty G., Carbon J.G., Grayburn P.A., Fleming J.B., Brekken R.A. Monitoring response to anticancer therapy by targeting microbubbles to tumor vasculature. Clin Cancer Res 2007, 13:323-330.
16. Leong-Poi H., Christiansen J., Heppner P., Lewis C.W., Klibanov A.L., Kaul SLindner J.R. Assessment of endogenous and therapeutic arteriogenesis by contrast ultrasound molecular imaging of integrin expression. Circulation 2005, 111:3248-3254.
17. Lyshchik A., Fleischer A.C., Huamani J., Hallahan D.E., Brissova M., Gore J.C. Molecular imaging of vascular endothelial growth factor receptor 2 expression using targeted contrast-enhanced high-frequency ultrasonography. JUltrasound Med 2007, 26:1575-1586.
18. Motzer R.J., Hutson T.E., Tomczak P., Michaelson M.D., Bukowski R.M., Rixe O., Oudard S., Negrier S., Szczylik C., Kim S.T., Chen I., Bycott P.W., Baum C.M., Figlin R.A. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. NEngl J Med 2007, 356:115-124.
19. Pochon S., Tardy I., Bussat P., Bettinger T., Brochot J., von Wronski M., Passantino L., Schneider M. BR55: A lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis. Invest Radiol 2010, 45:89-95.
20. Rini B.I., Campbell S.C., Escudier B. Renal cell carcinoma. Lancet 2009, 373:1119-1132.
21. Rini B.I., Escudier B., Tomczak P., Kaprin A., Szczylik C., Hutson T.E., Michaelson M.D., Gorbunova V.A., Gore M.E., Rusakov I.G., Negrier S., Ou Y.C., Castellano D., Lim H.Y., Uemura H., Tarazi J., Cella D., Chen C., Rosbrook B., Kim Sm Motzer R.J. Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): A randomised phase 3 trial. Lancet 2011, 378:1931-1939.
22. Rychak J.J., Graba J., Cheung A., Mystry B.S., Lindner J.R., Kerbel R.S., Foster F.S. Microultrasound molecular imaging of vascular endothelial growth factor receptor 2 in a mouse model of tumor angiogenesis. Mol Imaging 2007, 6:289-296.
23. Shibuya M. Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. JBiochem Mol Biol 2006, 39:469-478.
24. Streeter J.E., Herrera-Loeza S.G., Neel N.F., Yeh J.J., Dayton P.A. Acomparative evaluation of ultrasound molecular imaging, perfusion imaging, and volume measurements in evaluating response to therapy in patient-derived xenografts. Technol Cancer Res Treat 2013, 12:311-321.
25. Tardy I., Pochon S., Theraulaz M., Emmel P., Passantino L., Tranquart F., Schneider M. Ultrasound molecular imaging of VEGFR2 in a rat prostate tumor model using BR55. Invest Radiol 2010, 45:573-578.
26. Tartis M.S., Kruse D.E., Zheng H., Zhang H., Kheirolomoom A., Marik J., Ferrara K.W. Dynamic microPET imaging of ultrasound contrast agents and lipid delivery. JControl Release 2008, 131:160-166.
27. Terakawa T., Miyake H., Kusuda Y., Fujisawa M. Expression level of vascular endothelial growth factor receptor-2 in radical nephrectomy specimens as a prognostic predictor in patients with metastatic renal cell carcinoma treated with sunitinib. Urol Oncol 2011, 31:493-498.
28. Tsuchiya N., Sato K., Akao T., Kakinuma H., Sasaki R., Shimoda N., Satoh S., Habuchi T., Ogawa O., Kato T. Quantitative analysis of gene expressions of vascular endothelial growth factor-related factors and their receptors in renal cell carcinoma. Tohoku J Exp Med 2001, 195:101-113.
29. Vajkoczy P., Farhadi M., Gaumann A., Heidenreich R., Erber R., Wunder A., Tonn J.C., Menger M.D., Breier G. Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2. J Clin Invest 2002, 109:777-785.
30. Willmann J.K., Kimura R.H., Deshpande N., Lutz A.M., Cochran J.R., Gambhir S.S. Targeted contrast-enhanced ultrasound imaging of tumor angiogenesis with contrast microbubbles conjugated to integrin-binding knottin peptides. JNucl Med 2010, 51:433-440.
31. Willmann J.K., Lutz A.M., Paulmurugan R., Patel M.R., Chu P., Rosenberg J., Gambhir S.S. Dual-targeted contrast agent for US assessment of tumor angiogenesis invivo. Radiology 2008, 248:936-944.
32. Willmann J.K., Paulmurugan R., Chen K., Gheysens O., Rodriguez-Porcel M., Lutz A.M., Chen I.Y., Chen X., Gambhir S.S. US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. Radiology 2008, 246:508-518.
33. Yamashita Y., Takahashi M., Watanabe O., Yoshimatsu S., Ueno S., Ishimaru S., Kan M., Takano S., Ninomiya N. Small renal cell carcinoma: pathologic and radiologic correlation. Radiology 1992, 184:493-498.
34. Yanagisawa K., Moriyasu F., Miyahara T., Yuki M., Iijima H. Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells. Ultrasound Med Biol 2007, 33:318-325.